Child Behavior Disorders |
Bullying |
Clinical Trial: Family and Peer Involvement in the Treatment of Anxiety Disorders in Children
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to compare the effectiveness of family- and peer-oriented therapy in treating children with anxiety disorders.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Anxiety Disorders | Behavior: Cognitive Behavior Therapy | Phase I |
MedlinePlus related topics: Anxiety
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Therapy Specificity and Mediation in Family and Group CBT
Expected Total Enrollment: 250
Study start: July 2002; Expected completion: June 2007
Data suggest that individual Cognitive Behavior Therapy (CBT) is effective in reducing anxiety disorders in children. The incorporation of family and peers in a CBT treatment program may be more effective in reducing anxiety symptoms than CBT alone because a child's environment affects the development, course, and outcome of childhood psychopathology and functional status. This study will evaluate the effectiveness of family and peer involvement in CBT treatment.
Children and their parents will be randomly assigned to one of two treatment conditions: Family/Parents CBT (FCBT) or Peer/Group CBT (GCBT) for 14 to 16 weekly sessions. Parent-child relationships are the focus of the FCBT. Parents will be trained to manage their children's anxiety and avoidant behaviors by increasing acceptance and warmth toward their children. Children in the GCBT group will be trained to be more helpful and positive toward other children through role-playing activities. Interviews, questionnaires, and behavior observation tasks will be used to assess participants. All participants will be assessed at pretreatment, post-treatment, and at yearly follow-up visits for 5 years.
Eligibility
Ages Eligible for Study: 8 Years - 14 Years, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- DSM-IV criteria for Generalized Anxiety Disorder (GAD), Social Phobia (SP), or Separation Anxiety Disorder (SAD)
- Mean score >= 4 on the Clinician's Rating Scale of Severity
- Discontinuation of all other psychosocial treatment upon consultation with clinic staff and the service provider
- Discontinuation of stimulants for Attention Deficit Hyperactivity Disorder (ADHD) or other psychopharmacological agents that would confound the study
Exclusion Criteria:
- DSM-IV criteria for a disorder other than GAD, SP, and SAD
- Diagnosis of any one of the following: pervasive developmental disorders, mental retardation, selective mutism, organic mental disorders, or schizophrenia and other psychotic disorders
- At risk for harm to self or others
Location and Contact Information
Florida
Florida International University, Miami, Florida, 33174, United States; Recruiting
Wendy K. Silverman, PhD, Principal Investigator
William Kurtines, PhD, Sub-Investigator
More Information
Record last reviewed: October 2004
Last Updated: October 13, 2004
Record first received: December 2, 2003
ClinicalTrials.gov Identifier: NCT00073645
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


